Efficacy and Safety of Three Different Aflibercept Regimens in Subjects With Diabetic Macular Edema (DME)
Clinical trial NCT02818998 · COMPLETED
Trial details
- NCT number
- NCT02818998
- Sponsor
- Bayer
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2016-11-16
- Primary completion
- 2018-11-13
- Enrollment
- 463
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.